NEXN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nexxen International Ltd (NEXN) is not a strong buy for a long-term beginner investor at this moment. While there are some positive indicators, such as the MACD showing bullish momentum and analysts maintaining Buy ratings, the stock's overbought RSI, mixed financial performance, and lack of significant positive catalysts suggest that it may not be the best time to enter. Additionally, the stock's trend analysis indicates potential short-term downside risk, which could make this a less favorable entry point for a long-term investor.
The MACD histogram is positive at 0.0651 and expanding, signaling bullish momentum. However, the RSI is at 82.104, indicating the stock is overbought. Moving averages are converging, suggesting indecision in the market. Key resistance levels are at 7.313 and 7.567, with support at 6.487 and 6.233. The stock is trading near its resistance levels, which could limit further upside in the short term.
Analysts maintain Buy ratings with price targets ranging from $10 to $16, indicating potential upside. The MACD shows bullish momentum, and the stock has a chance of a 6.22% gain over the next month based on candlestick analysis.
RSI indicates the stock is overbought, suggesting a potential pullback. Financial performance in Q3 2025 showed significant declines in net income (-71.06% YoY) and EPS (-65% YoY). No recent news or significant trading activity from insiders or hedge funds. Stock trend analysis indicates a 70% chance of a -6.6% decline in the next week.
In Q3 2025, revenue increased by 5.11% YoY to $94.79M, but net income dropped by 71.06% YoY to $4.21M. EPS fell by 65% YoY to $0.07, and gross margin declined by 6.54% YoY to 65.88%. The financials show mixed results, with growth in revenue but significant declines in profitability.
Analysts have mixed views. Rosenblatt raised the price target to $16, citing potential recovery in 2026. Scotiabank and Canaccord lowered price targets to $10 and $11, respectively, but maintained Outperform and Buy ratings. Analysts acknowledge mixed Q4 results but are optimistic about future guidance.
